首页> 外国专利> GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR

GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR

机译:使用Reg肽,肽模拟物,小分子和刺激抗体来产生脑和脊髓神经元,心肌细胞和肝细胞的肝癌和肝细胞

摘要

Reg gene receptors are found throughout the body, including in the neurons of the brain and spinal cord, liver and heart. Reg proteins are expressed during fetal development for organogenesis and then only upregulated in times of organ injury, such as in the setting of stroke, myocardial infarction or spinal cord injury. Upregulation of Reg proteins following organ injury is a protective mechanism against organ failure and has been shown to result in the formation of new neurons, cardiac myocytes, hepatocytes and in other organs expressing the Reg receptor. Described are the compositions of bioactive Reg peptides, as well as optimization of these peptides (to increase plasma half-life), peptidomimetics, stimulatory antibodies and small molecules that interact with the Reg receptor that are capable of initiating formation of new cells after organ injury.
机译:在整个身体中发现reg基因受体,包括在脑和脊髓,肝脏和心脏的神经元中。 Reg蛋白在有机组织的胎儿发育过程中表达,然后仅在器官损伤时上调,例如在中风,心肌梗死或脊髓损伤的设置中。 室内器官损伤后雷蛋白的上调是对器官衰竭的保护机制,并且已被证明可以形成新神经元,心脏肌细胞,肝细胞和表达雷科受体的其他器官。 描述的是生物活性序列肽的组合物,以及这些肽的优化(以增加血浆半衰期),肽模拟物,刺激抗体和小分子,其与reg受体相互作用,该诱导受体能够在器官损伤后发起新细胞的形成 。

著录项

  • 公开/公告号US2021371478A1

    专利类型

  • 公开/公告日2021-12-02

    原文格式PDF

  • 申请/专利权人 CLARESA LEVETAN;

    申请/专利号US202117391883

  • 发明设计人 CLARESA LEVETAN;

    申请日2021-08-02

  • 分类号C07K14/47;A61K35/12;C07K16/28;A61K38/08;

  • 国家 US

  • 入库时间 2022-08-24 22:34:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号